Rosie O'Donnell Shares Her Gradual Approach to Mounjaro Weight Loss Without Side Effects

Rosie O'Donnell disclosed her three-year Mounjaro regimen, gradually increasing doses to shed 65 pounds without experiencing medication side effects.

3 dk okuma 9 görüntülenme
rosie o'donnell

Rosie O'Donnell revealed her strategy for losing approximately 65 pounds over three years using the diabetes medication Mounjaro, emphasizing a gradual dosage increase that allowed her to avoid common side effects. Speaking on the "Bleep! With Ana Navarro" podcast, the comedian described taking the lowest available dose for an extended period before incrementally raising her medication levels, a deliberate approach she credited with preventing adverse reactions.

İçindekiler

The Three-Year Dosing Strategy

O'Donnell detailed her specific dosage progression to listeners. She began at 2.5 milligrams for the first year, advanced to 5 milligrams in year two, and entered the third year at 7.5 milligrams. This measured approach differed significantly from standard treatment protocols, which typically start patients at 2.5 milligrams with more rapid escalation based on individual tolerance.

The 64-year-old explained her reasoning for the slower pace: she recognized that rapid weight loss had previously overwhelmed her emotionally and physically. "I wanted to go slow because I know that it overwhelms me when I have lost weight quick before," O'Donnell told Navarro. "I like doing it at a slow pace. I like how it feels that I'm not sick, that I've never had any kind of side effects."

Managing Expectations and Results

O'Donnell was diagnosed with Type 2 diabetes three years prior and began taking Mounjaro approximately two months before her initial public disclosure. She previously described the medication as a "miracle drug," particularly noting how it reduced her preoccupation with food—a longstanding challenge in her weight management journey. Despite avoiding the gastrointestinal complications commonly reported with GLP-1 medications, she experienced facial volume loss necessitating cosmetic procedures.

In January, she underwent a facelift to address deepened facial lines that had become more pronounced following her weight loss. O'Donnell reflected on this decision through a personal essay, noting her evolving perspective on cosmetic procedures she had previously considered incompatible with her feminist values. The procedure represented a significant shift in her willingness to address aging-related changes resulting from her transformation.

What dosage schedule did Rosie O'Donnell follow?+
O'Donnell started at 2.5 milligrams for one year, then 5 milligrams for the second year, and progressed to 7.5 milligrams in her third year of treatment. She plans to increase the dose one additional time before maintaining her current level.
What is Mounjaro's primary medical purpose?+
Mounjaro is FDA-approved to treat Type 2 diabetes. The medication is produced by Eli Lilly and has become associated with weight loss effects, leading to broader usage beyond its original indication.
What common side effects did O'Donnell avoid?+
Mounjaro's typical side effects include nausea, vomiting, indigestion, and stomach pain. O'Donnell reported never experiencing any of these complications despite taking the medication for three years.
How much weight did Rosie O'Donnell lose?+
O'Donnell lost approximately 65 pounds over her three-year treatment period with Mounjaro, representing a gradual transformation that aligned with her preferred pace of weight management.
Why did O'Donnell choose a slower dosing approach?+
O'Donnell deliberately selected gradual dose increases to avoid being overwhelmed by rapid weight loss, which she had experienced negatively in the past. She preferred feeling physically well throughout the process and avoiding medication side effects.

Bülten Aboneliği

Haftada bir, teknoloji ve dijital dünyadan seçtiklerimiz e-postanda. Spam yok, sadece içerik.

Benzer Haberler

Yorumlar

0
Henüz yorum yok. İlk yorumu sen yap!
app store'da indir